645403-12-9

Upstream product

• 645402-97-7 5-O-benzoyl-3-O-benzyl-1,2-O-cyclohexylidene-α-D-xylofuranose 
• 645403-04-9 methyl 3-O-benzyl-5,6-dideoxy-1,2-O-cyclohexylidene-α-D-xylo-heptofuranuronate 
• 645403-02-7 3-O-benzyl-1,2-O-cyclohexilidene-α-D-xylofuranose 
• 15354-75-3 3-O-benzyl-1,2-O-cyclohexylidene-α-D-xylo-pentodialdo-1,4-furanose 
• 645403-07-2 methyl 2-O-benzyl-4,5-dideoxy-3-O-formyl-D-threo-hexuronate 
• 100-39-0 benzyl bromide 

Downstream Products

• 916649-43-9 5-O-benzyl-2,3-dideoxy-D-threo-hexono-1,4-lactone 
• 916649-44-0 5-O-benzyl-6-O-decyl-2,3-dideoxy-D-threo-hexono-1,4-lactone 

Relevant academic research and scientific papers

Enantiodivergent synthesis of muricatacin related lactones from d-xylose based on the latent symmetry concept: preparation of two?novel cytotoxic (+)- and (-)-muricatacin 7-oxa analogs

Enantiodivergent formal synthesis of (+)- and (-)-muricatacins from d-xylose has been accomplished through utilization of the?latent plane of symmetry present in the starting monosaccharide. This approach was extended to the preparation of two novel (+)-

Enantiopure hydroxylactones from D-xylose. A novel approach to the enantiodivergent synthesis of (+)- and (-)-muricatacin suitable for the preparation of 7-oxa analogues

A new route towards enantiopure hydroxylactones 3 and ent-3, the final chiral precursors in an enantiodivergent synthesis of (+)- and (-)-muricatacin, has been developed starting from D-xylose.